- Home
- ALDX vs AUDC Comparison
ALDX vs AUDC Comparison
Compare ALDX & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- AUDC
- Stock Information
- Founded
- ALDX 2004
- AUDC 1992
- Country
- ALDX United States
- AUDC Israel
- Employees
- ALDX N/A
- AUDC N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- AUDC Telecommunications Equipment
- Sector
- ALDX Health Care
- AUDC Utilities
- Exchange
- ALDX Nasdaq
- AUDC Nasdaq
- Market Cap
- ALDX 304.9M
- AUDC 299.7M
- IPO Year
- ALDX 2014
- AUDC 1999
- Fundamental
- Price
- ALDX $6.55
- AUDC $10.02
- Analyst Decision
- ALDX Strong Buy
- AUDC Buy
- Analyst Count
- ALDX 2
- AUDC 2
- Target Price
- ALDX $10.00
- AUDC $11.25
- AVG Volume (30 Days)
- ALDX 698.6K
- AUDC 73.6K
- Earning Date
- ALDX 05-01-2025
- AUDC 05-06-2025
- Dividend Yield
- ALDX N/A
- AUDC 1.82%
- EPS Growth
- ALDX N/A
- AUDC 78.82
- EPS
- ALDX N/A
- AUDC 0.50
- Revenue
- ALDX N/A
- AUDC $242,176,000.00
- Revenue This Year
- ALDX N/A
- AUDC $5.11
- Revenue Next Year
- ALDX N/A
- AUDC $3.79
- P/E Ratio
- ALDX N/A
- AUDC $19.78
- Revenue Growth
- ALDX N/A
- AUDC N/A
- 52 Week Low
- ALDX $2.85
- AUDC $7.70
- 52 Week High
- ALDX $7.20
- AUDC $13.71
- Technical
- Relative Strength Index (RSI)
- ALDX 54.11
- AUDC 39.36
- Support Level
- ALDX $6.22
- AUDC $9.85
- Resistance Level
- ALDX $6.87
- AUDC $10.69
- Average True Range (ATR)
- ALDX 0.44
- AUDC 0.27
- MACD
- ALDX -0.03
- AUDC -0.04
- Stochastic Oscillator
- ALDX 56.30
- AUDC 23.23
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells advanced and converged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.